Human Chorionic Gonadotropin (hCG) Market By Technology, Therapeutic Area and Source Type - Global Industry Analysis & Forecast to 2027
Published On : November 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC111597
Human Chorionic Gonadotropin (hCG) Market By Technology (Recombinant Technology, Natural Source Extraction) Therapeutic Area (Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Others) End User (Research Institutions, Fertility Clinics, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Human Chorionic Gonadotropin (hCG) Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Human chorionic gonadotropin (hCG) comes from the group of gonadotropin hormones and is naturally created by the placenta. hCG hormone has a vital role after the development of the fetus, and henceforth has increased critical footing throughout the years for the treatment of infertility in women and men. hCG triggers ovulation in ladies and helps with expanding the sperm count in men.
Drivers and Restraints
Ascend in rate of issues related with infertility in both the sexes drive the development of the worldwide hCG market. Also, upsurge in the implementation of hCG hormone in management of pain and weight reduction move the market development. Moreover, advent of recombinant innovation for the advancement of hCG is foreseen to offer lucrative chances for the market development in the upcoming years.
Regional Insights
North America dominated the market in 2022 and is foreseen to continue its dominance over the forecast period. This is credited to major increase in incidence of infertility-related issues in both sexes.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Merck & Co., Inc
- Fresenius Kabi AG
- Sun Pharmaceutical Industries Ltd
- Sanzyme
- Lupin AB
- Bristol Myers Squibb Company
- Ferring B.V
- Cigna
- Lee BioSolutions Inc
- Scripps Laboratories
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Human Chorionic Gonadotropin (hCG) Market, By Technology, Estimates and Forecast, 2017-2027($Billion)
o Recombinant Technology
o Natural Source Extraction
· Human Chorionic Gonadotropin (hCG) Market, By Therapeutic Area, Estimates and Forecast, 2017-2027($Billion)
o Male Hypogonadism
o Female Infertility Treatment
o Oligospermic Treatment
o Others
· Human Chorionic Gonadotropin (hCG) Market, By End User, Estimates and Forecast, 2017-2027($Billion)
o Research Institutions
o Fertility Clinics
o Others
· Human Chorionic Gonadotropin (hCG) Market, By Region, Estimates and Forecast, 2017-2027($Billion)
o North America
§ North America Human Chorionic Gonadotropin (hCG) Market, By Country
o U.S. Human Chorionic Gonadotropin (hCG) Market
o Canada Human Chorionic Gonadotropin (hCG) Market
o Mexico Human Chorionic Gonadotropin (hCG) Market
o Europe
§ Europe Human Chorionic Gonadotropin (hCG) Market, By Country
o Germany Human Chorionic Gonadotropin (hCG) Market
o UK Human Chorionic Gonadotropin (hCG) Market
o France Human Chorionic Gonadotropin (hCG) Market
o Russia Human Chorionic Gonadotropin (hCG) Market
o Italy Human Chorionic Gonadotropin (hCG) Market
o Rest of Europe Human Chorionic Gonadotropin (hCG) Market
o Asia-Pacific
§ Asia-Pacific Human Chorionic Gonadotropin (hCG) Market, By Country
o China Human Chorionic Gonadotropin (hCG) Market
o Japan Human Chorionic Gonadotropin (hCG) Market
o South Korea Human Chorionic Gonadotropin (hCG) Market
o India Human Chorionic Gonadotropin (hCG) Market
o Southeast Asia Human Chorionic Gonadotropin (hCG) Market
o Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Market
o South America
§ South America Human Chorionic Gonadotropin (hCG) Market
o Brazil Human Chorionic Gonadotropin (hCG) Market
o Argentina Human Chorionic Gonadotropin (hCG) Market
o Columbia Human Chorionic Gonadotropin (hCG) Market
o Rest of South America Human Chorionic Gonadotropin (hCG) Market
o Middle East and Africa
§ Middle East and Africa Human Chorionic Gonadotropin (hCG) Market
o Saudi Arabia Human Chorionic Gonadotropin (hCG) Market
o UAE Human Chorionic Gonadotropin (hCG) Market
o Egypt Human Chorionic Gonadotropin (hCG) Market
o Nigeria Human Chorionic Gonadotropin (hCG) Market
o South Africa Human Chorionic Gonadotropin (hCG) Market
o Rest of MEA Human Chorionic Gonadotropin (hCG) Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Human Chorionic Gonadotropin (hCG) Market, By Technology
5.1. Introduction
5.2. Global Human Chorionic Gonadotropin (hCG) Revenue and Market Share by Technology (2017-2027)
5.2.1. Global Human Chorionic Gonadotropin (hCG) Revenue and Revenue Share by Technology (2017-2027)
5.3. Recombinant Technology
5.3.1. Global Recombinant Technology Revenue and Growth Rate (2017-2027)
5.4. Natural Source Extraction
5.4.1. Global Natural Source Extraction Revenue and Growth Rate (2017-2027)
6. Human Chorionic Gonadotropin (hCG) Market, By Therapeutic Area
6.1. Introduction
6.2. Global Human Chorionic Gonadotropin (hCG) Revenue and Market Share by Therapeutic Area (2017-2027)
6.2.1. Global Human Chorionic Gonadotropin (hCG) Revenue and Revenue Share by Therapeutic Area (2017-2027)
6.3. Male Hypogonadism
6.3.1. Global Male Hypogonadism Revenue and Growth Rate (2017-2027)
6.4. Female Infertility Treatment
6.4.1. Global Female Infertility Treatment Revenue and Growth Rate (2017-2027)
6.5. Oligospermic Treatment
6.5.1. Global Oligospermic Treatment Revenue and Growth Rate (2017-2027)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2027)
7. Human Chorionic Gonadotropin (hCG) Market, By End User
7.1. Introduction
7.2. Global Human Chorionic Gonadotropin (hCG) Revenue and Market Share by End User (2017-2027)
7.2.1. Global Human Chorionic Gonadotropin (hCG) Revenue and Revenue Share by End User (2017-2027)
7.3. Research Institutions
7.3.1. Global Research Institutions Revenue and Growth Rate (2017-2027)
7.4. Fertility Clinics
7.4.1. Global Fertility Clinics Revenue and Growth Rate (2017-2027)
7.5. Others
7.5.1. Global Others Revenue and Growth Rate (2017-2027)
8. Human Chorionic Gonadotropin (hCG) Market, By Region
8.1. Introduction
8.2. Global Human Chorionic Gonadotropin (hCG) Revenue and Market Share by Regions
8.2.1. Global Human Chorionic Gonadotropin (hCG) Revenue by Regions (2017-2027)
8.3. North America Human Chorionic Gonadotropin (hCG) by Countries
8.3.1. North America Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2027)
8.3.2. North America Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Human Chorionic Gonadotropin (hCG) by Countries
8.4.1. Europe Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2027)
8.4.2. Europe Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Human Chorionic Gonadotropin (hCG) by Countries
8.5.1. Asia-Pacific Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Human Chorionic Gonadotropin (hCG) by Countries
8.6.1. South America Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2027)
8.6.2. South America Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Human Chorionic Gonadotropin (hCG) by Countries
8.7.1. Middle East and Africa Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Merck & Co., Inc
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Fresenius Kabi AG
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Sun Pharmaceutical Industries Ltd
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Sanzyme
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Lupin AB
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Bristol Myers Squibb Company
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Ferring B.V
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Cigna
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Lee BioSolutions Inc
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. Scripps Laboratories
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
10. Global Human Chorionic Gonadotropin (hCG) Market Competition, by Manufacturer
10.1. Global Human Chorionic Gonadotropin (hCG) Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Human Chorionic Gonadotropin (hCG) Price By Region (2017-2017)
10.3. Top 5 Human Chorionic Gonadotropin (hCG) Manufacturer Market Share
10.4. Market Competition Trend
11. Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.1. Global Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Human Chorionic Gonadotropin (hCG) Market Forecast by Regions (2017-2027)
11.2.1. North America Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.1.1. United States Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.1.2. Canada Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.1.3. Mexico Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.2. Europe Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.2.1. Germany Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.2.2. France Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.2.3. UK Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.2.4. Russia Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.2.5. Italy Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.3. Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.3.1. China Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.3.2. Japan Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.3.3. Korea Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.3.4. India Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.4. South America Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.4.1. Brazil Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.4.2. Argentina Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.4.3. Columbia Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.4.4. Rest of South America Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.5. Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.5.3. Egypt Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.5.4. Nigeria Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.5.5. South Africa Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.5.6. Turkey Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Forecast (2017-2027)
11.3. Human Chorionic Gonadotropin (hCG) Market Forecast by Technology (2017-2027)
11.3.1. Human Chorionic Gonadotropin (hCG) Forecast by Technology (2017-2027)
11.3.2. Human Chorionic Gonadotropin (hCG) Market Share Forecast by Technology (2017-2027)
11.4. Human Chorionic Gonadotropin (hCG) Market Forecast by Therapeutic Area (2017-2027)
11.4.1. Human Chorionic Gonadotropin (hCG) Forecast by Therapeutic Area (2017-2027)
11.4.2. Human Chorionic Gonadotropin (hCG) Market Share Forecast by Therapeutic Area (2017-2027)
11.5. Human Chorionic Gonadotropin (hCG) Market Forecast by End User (2017-2027)
11.5.1. Human Chorionic Gonadotropin (hCG) Forecast by End User (2017-2027)
11.5.2. Human Chorionic Gonadotropin (hCG) Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Human Chorionic Gonadotropin (hCG) Revenue and Revenue Share by Technology (2017-2018)
Figure Global Recombinant Technology Revenue and Growth Rate (2017-2018)
Figure Global Natural Source Extraction Revenue and Growth Rate (2017-2018)
Table Global Human Chorionic Gonadotropin (hCG) Revenue and Revenue Share by Therapeutic Area (2017-2018)
Figure Global Male Hypogonadism Revenue and Growth Rate (2017-2018)
Figure Global Female Infertility Treatment Revenue and Growth Rate (2017-2018)
Figure Global Oligospermic Treatment Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Human Chorionic Gonadotropin (hCG) Revenue and Revenue Share by End User (2017-2018)
Figure Global Research Institutions Revenue and Growth Rate (2017-2018)
Figure Global Fertility Clinics Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Human Chorionic Gonadotropin (hCG) Revenue by Regions (2017-2018)
Figure North America Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure North America Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2018)
Figure North America Human Chorionic Gonadotropin (hCG) by Countries (2017-2018)
Figure North America Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2018)
Figure United States Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure United States Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Canada Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Mexico Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Europe Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2018)
Figure Europe Human Chorionic Gonadotropin (hCG) by Countries (2017-2018)
Figure Europe Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2018)
Figure Germany Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Germany Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure France Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure UK Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Russia Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Italy Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Rest of Europe Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Asia-Pacific Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Human Chorionic Gonadotropin (hCG) by Countries (2017-2018)
Figure Asia-Pacific Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2018)
Figure China Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure China Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Japan Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Korea Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure India Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Southeast Asia Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure South America Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2018)
Figure South America Human Chorionic Gonadotropin (hCG) by Countries (2017-2018)
Figure South America Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Brazil Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Argentina Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Columbia Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Rest of South America Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Middle East and Africa Human Chorionic Gonadotropin (hCG) Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Human Chorionic Gonadotropin (hCG) by Countries (2017-2018)
Figure Middle East and Africa Human Chorionic Gonadotropin (hCG) Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Saudi Arabia Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure United Arab Emirates Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Egypt Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Nigeria Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure South Africa Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Turkey Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2017-2018)
Table Merck & Co., Inc Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Fresenius Kabi AG Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanzyme Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lupin AB Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bristol Myers Squibb Company Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ferring B.V Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cigna Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lee BioSolutions Inc Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Scripps Laboratories Human Chorionic Gonadotropin (hCG) Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Human Chorionic Gonadotropin (hCG) Market Share by Manufacturer
Figure Global Human Chorionic Gonadotropin (hCG) Revenue and Market Share by Manufacturer
Table Global Human Chorionic Gonadotropin (hCG) Price by Region (2017-2017)
Figure Top 5 Human Chorionic Gonadotropin (hCG) Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Human Chorionic Gonadotropin (hCG) Revenue (Millions USD) and Growth Rate (2018-2025)
Table Human Chorionic Gonadotropin (hCG) Market Forecast by Regions (2018-2025)
Figure North America Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure United States Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Canada Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Mexico Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Europe Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Germany Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure France Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure UK Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Russia Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Italy Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Rest of Europe Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure China Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Japan Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Korea Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure India Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Southeast Asia Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure South America Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Brazil Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Argentina Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Columbia Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Rest of South America Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Saudi Arabia Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure United Arab Emirates Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Egypt Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Nigeria Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure South Africa Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Turkey Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Human Chorionic Gonadotropin (hCG) Market Forecast (2018-2025)
Figure Global Human Chorionic Gonadotropin (hCG) Forecast by Technology (2018-2025)
Figure Global Human Chorionic Gonadotropin (hCG) Market Share Forecast by Technology (2018-2025)
Figure Global Human Chorionic Gonadotropin (hCG) Forecast by Technology (2018-2025)
Figure Global Human Chorionic Gonadotropin (hCG) Forecast by Therapeutic Area (2018-2025)
Figure Global Human Chorionic Gonadotropin (hCG) Market Share Forecast by Therapeutic Area (2018-2025)
Figure Global Human Chorionic Gonadotropin (hCG) Forecast by Therapeutic Area (2018-2025)
Figure Global Human Chorionic Gonadotropin (hCG) Forecast by End User (2018-2025)
Figure Global Human Chorionic Gonadotropin (hCG) Market Share Forecast by End User (2018-2025)
Figure Global Human Chorionic Gonadotropin (hCG) Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|